Hiroomi Tada
2021
In 2021, Hiroomi Tada earned a total compensation of $2.5M as Chief Medical Officer at Tyra Biosciences.
Compensation breakdown
Non-Equity Incentive Plan | $114,735 |
---|---|
Option Awards | $1,991,713 |
Salary | $403,778 |
Other | $1,135 |
Total | $2,511,361 |
Tada received $2M in option awards, accounting for 79% of the total pay in 2021.
Tada also received $114.7K in non-equity incentive plan, $403.8K in salary and $1.1K in other compensation.
Rankings
In 2021, Hiroomi Tada's compensation ranked 5,134th out of 12,415 executives tracked by ExecPay. In other words, Tada earned more than 58.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,134 | 59th |
Manufacturing | 2,161 | 61st |
Chemicals And Allied Products | 930 | 61st |
Drugs | 831 | 60th |
Pharmaceutical Preparations | 595 | 62nd |
Tada's colleagues
We found three more compensation records of executives who worked with Hiroomi Tada at Tyra Biosciences in 2021.